Prelude Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-466
| Closed | -$33K | – | 1638 |
|
|
2020
Q2 | $33K | Buy |
466
+62
| +15% | +$4.39K | ﹤0.01% | 871 |
|
|
2020
Q1 | $18K | Sell |
404
-303
| -43% | -$13.5K | ﹤0.01% | 674 |
|
|
2019
Q4 | $46K | Buy |
+707
| New | +$46K | ﹤0.01% | 966 |
|
|
2018
Q4 | – | Sell |
-90
| Closed | -$15K | – | 1593 |
|
|
2018
Q3 | $15K | Buy |
+90
| New | +$15K | ﹤0.01% | 1023 |
|
|
2017
Q3 | – | Sell |
-3,163
| Closed | -$240K | – | 1647 |
|
|
2017
Q2 | $240K | Buy |
+3,163
| New | +$240K | 0.02% | 466 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1622 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 1639 |
|
|
2016
Q2 | – | Sell |
-739
| Closed | -$49K | – | 1596 |
|
|
2016
Q1 | $49K | Buy |
+739
| New | +$49K | 0.01% | 905 |
|
|
2015
Q3 | – | Sell |
-401
| Closed | -$25K | – | 1548 |
|
|
2015
Q2 | $25K | Buy |
+401
| New | +$25K | ﹤0.01% | 1224 |
|
|
2015
Q1 | – | Sell |
-1,122
| Closed | -$37K | – | 1957 |
|
|
2014
Q4 | $37K | Buy |
1,122
+160
| +17% | +$5.28K | 0.01% | 1374 |
|
|
2014
Q3 | $28K | Sell |
962
-9,618
| -91% | -$280K | ﹤0.01% | 1559 |
|
|
2014
Q2 | $411K | Buy |
+10,580
| New | +$411K | 0.05% | 395 |
|